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11241 women who delivered in Shanghai First Maternity and Infant
Hospital and Shanghai Tenth People’s Hospital. Multivariate logistic
regression analysis was conducted to explore potential risk factors
of GDM. Moreover, longitudinal comparison of ten years period
were made.
RESULTS According to National Diabetes Data Group (NDDG) Stan-
dard, the incidences of GDM were 2.69% and 5.59% in 2001 and 2010,
respectively. The older were the subjects group, the higher the inci-
dence of GDM would be both in 2001 and 2010 (P < 0.01), and the
incidences of GDM in two subgroups (25-29 yrs, 30-34 yrs group) were
higher in 2010 than those in 2001. In addition, the incidence of GDM
increased signiﬁcantly with elevated body mass index (BMI) in 2010
(P < 0.01). As shown in multivariate logistic regression models,
BMI and hemoglobin were independent risk factors for GDM in 2001,
Odds ratio (OR) values and its 95% conﬁdence interval (CI) were 2.54
(1.12-5.75) and 1.04 (1.01-1.06), respectively. However, independent
risk factors for GDM in 2010 included BMI  24 kg/m2, obstetric ab-
normality, history of diabetes and systolic blood pressure, OR value
and 95%CI were 2.06 (1.63-2.61), 1.44 (1.04-2.00), 3.02 (1.94-4.72), 1.01
(1.00-1.02). Noteworthy, maternal age was also an independent risk
factor for GDM in 2010, the older were the subjects group, the higher
OR would be. OR (95%CI) of three subgroups (25-29 yrs, 30-34 yrs and
over 35 yrs group) were 2.81 (1.30-6.06), 4.70 (2.18-10.15), 7.99 (3.59-
17.76), respectively. Height was a protective factor for GDM, its OR
(95%CI) was 0.98 (0.97-0.99).
CONCLUSIONS The increasing incidence of GDM in combined with
changes of risk factors indicates a signiﬁcant public burden on health
services. More effective management and timely intervention
regarding these high-risk pregnancies will also need to be addressed
in the future.GW26-e2968
Selenium prevents from atherosclerosis formation by maintaining
antioxidant activation through the Akt/ GSK3b/ Nrf2 axis in diabetes
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OBJECTIVES The essential trace element, selenium (Se), has multiple
biological activities. The present study aimed to evaluate the effect of
antioxidant capacity mobilized by selenium-regulated Nrf2 on
atherosclerosis formation in diabetes mellitus and possible
mechanisms.
METHODS 20 male Sprague- Dawley rats were randomly assigned into
2 groups: STZ-induced diabetes with Se supplementation group
(DMþSeS, 1 mg selenium/kg diet was given for 5 weeks every day) and
STZ-induced diabetes with Se-deﬁcient group (DMþSeD, 0.05mg
selenium/kg diet was given for 5 weeks every day). Atherosclerotic
plaques were stained with Oil-red-O and counterstained with hema-
toxylin. Both oxidative stress and antioxidant capacity were
measured. Expression of phosphorylation of Akt/GSK3b and Nrf2 and
Fyn expression were examined by Western blot.
RESULTS Compared with DMþSeD, Se supplementation in diabetic
rats signiﬁcantly increased serum Se levels (12620ug/L in SeS vs.
4015 ug/L in SeD group, P<0.05) and inhibited atherosclerotic pla-
ques formation along with increased antioxidant selenoenzymes
glutathione peroxidase (GPx) activity(31%, P<0.05), the GSH concen-
tration (18%, P<0.05) and HO-1 expression(23%, P<0.05) in artery
tissue. Contrarily, decreased ROS generation and lipid peroxidation
(LP) levels were observed. Se supplementation also showed a signif-
icant enhance in nuclear factor-erythroid 2-related factor 2 (Nrf2)
expression and transcription action along with signiﬁcant increases in
Akt and GSK-3b phosphorylation, and decrease in nuclear accumula-
tion of Fyn (a Nrf2 negative regulator). In vitro study with endothelial
cells showed that high glucose-induced oxidative stress could be
completely prevented by simultaneous Se supplementation.
Furthermore, increased phosphorylation of Akt and GSK3b and Nrf2
transcription action by Se addition were also blocked by the Akt in-
hibitor MK2206 and Akt negative regulators PTEN, which was
accompanied by increase in nuclear accumulation of Fyn.
CONCLUSIONS It is suggested that Se is required for maintaining
antioxidant activation through the Akt/ GSK3b/ Fyn -Nrf2/ axis indiabetic condition. Se supplementation may be useful for preventing
from atherosclerosis development in diabetes.GW26-e1008
Comparison of Invasive Versus Conservative Strategy for the Treatment of
Diabetes Mellitus with Acute Coronary Syndromes: A Meta-Analysis of
Randomized Controlled Trials
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OBJECTIVES The aim of this study was to compare the outcomes of
invasive versus conservative strategy in diabetes mellitus (DM) pa-
tients with acute coronary syndrome (ACS).
METHODS 9 randomized, controlled trials (RCT) involving 1,789 pa-
tients were included. We evaluated the risk ratios (RR) and 95%
conﬁdence intervals (Cls) of myocardial infarction (MI) following
invasive versus conservative strategy for DM patients with ACS as
primary endpoints. The rates of death and rehospitalization with ACS
were secondary endpoints.
RESULTS In a comparison of conservative strategy, the rates of MI
(RR: 0.71; 95% CI: 0.55 to 0.92, p < 0.01) and rehospitalization with
ACS (RR: 0.75; 95% CI: 0.61 to 0.92, p < 0.01) of invasive strategy for
DM patients with ACS were signiﬁcantly lower. There was no signiﬁ-
cant difference in death (RR: 1.01; 95% CI: 0.70 to 1.45, p > 0.05) be-
tween invasive and conservative strategy groups.
CONCLUSIONS In DM patients with ACS, invasive strategy comparing
with conservative strategy reduced the risk of MI and rehospitaliza-
tion with ACS.GW26-e2329
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OBJECTIVES AEML is the aqueous extract from Mulberry leaf which
can inhibit the active of a- Glycosidase. This study is to investigate the
effect of AEML on the Glycaemic Index (GI) of common carbohydrates
in Chinese healthy subjects.
METHODS A seven-period, self-crossover, open-label clinical trial
was performed to 15 healthy male and female volunteers. In each
period, all the subjects received a mixture of sugar þ test substance
dissolved in water as a meal. Reference meal is Glucose 50 g, while
test meals are Glucose 50 g þ AEML 750 mg, Maltose 50 g þ AEML
750 mg, Sucrose 50 g þ AEML 750 mg and Maltodextrin 50 g þ
AEML 750 mg. Each subject randomly received the reference meal
three times and the test meal once in a cycle. There was a 2-day
washout period between each administration. The blood samples
were taken from ﬁnger-prick at –15 min, 0 min and intervals of 15,
30, 45, 60, 90 and 120 min after consuming the test/reference
meals. These incremental area under the curve (IAUC) of blood
sugar–time curve were inspected about reference meal and test
meals.
RESULTS The GI of common carbohydrates treated by AEML is great
difference compared with no AEML groups. The IAUC values for
Glucose, Glucose þ AEML, Maltose þ AEML, Sucrose þ AEML and
Maltodextrin þ AEML were 181.9553.56, 170.8442.28,
107.1354.68, 90.4032.30, and 126.7336.00 (mmol/L$min), respec-
tively. Furthermore, the GI value of Glucose, Maltose, Sucrose and
Maltodextrin were 94, 59, 50 and 70, less than the corresponding re-
ported value 100, 105, 65 and 110, respectively.
CONCLUSIONS AEML can reduce the GI level of Glucose, Maltose,
Sucrose and Maltodextrin in healthy male and female volunteers. It
has potential to serve as a good food additives for diabetic or predi-
abetic patients.
